In squamous cell carcinomas, TP53 mutations and hypoxia activating the HIF‐1 pathway and PI3K/AKT signaling are associated with glucose metabolism‐related markers and could be the main drivers of metabolism in this histological subtype. This evidence concerns the gene TP53 and squamous cell carcinoma.